Research Article

Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients

Table 1

Clinicopathologic characteristics of nonmelanoma skin cancer patients and their respective IL-27 serum levels in each subgroup.

VariablesN( valid percent)IL-27 serum level(ng/ml)P-value1

GenderMale45(75.0%)0.007150.070
Female15(25.0%)0.0989

PathologySCC40(66.7%)0.016150.621
BCC20(33.3%)0.00995

Tumor SiteSun-exposed54(93.10%)0.01340.091
Not Sun-exposed4(6.90%)0.2812

Multiple lesionsYes8(16.67%)0.05890.778
No40(83.33%)0.0134

Mann-whitney U-test.